Back
  1. Home
  2. Profile of Christophe CELLO (ULiège)
Profil

CELLO Christophe

Unilab > Laboratoire Biochimie Génétique

See author's contact details
Main Referenced Co-authors
Boemer, François  (7)
Marcillaud-Pitel, Christel (6)
Votion, Dominique  (6)
Richard, Eric (5)
Amory, Hélène  (4)
Main Referenced Keywords
cheval (4); Horse (4); myopathie atypique (4); Acer (3); atypical myopathy (3);
Main Referenced Unit & Research Centers
FARAH - Fundamental and Applied Research for Animals and Health - ULiège [BE] (6)
Main Referenced Disciplines
Veterinary medicine & animal health (6)
Pediatrics (1)

Publications (total 7)

The most downloaded
59 downloads
BOEMER, F., JOSSE, C., LUIS, G., Di Valentin, E., Thiry, J., CELLO, C., CABERG, J.-H., DADOUMONT, C., HARVENGT, J., Lumaka, A., BOURS, V., & DEBRAY, F.-G. (18 February 2022). Novel Loss of Function Variant in BCKDK Causes a Treatable Developmental and Epileptic Encephalopathy. International Journal of Molecular Sciences, 23 (4), 2253. doi:10.3390/ijms23042253 https://hdl.handle.net/2268/289547

The most cited

23 citations (Scopus®)

BOEMER, F., Detilleux, J., CELLO, C., Amory, H., Marcillaud-Pitel, C., Richard, E., Van Galen, G., van Loon, G., Lefère, L., & Votion, D. (2017). Acylcarnitines profile best predicts survival in horses with atypical myopathy. PLoS ONE, 1-16. doi:10.1371/journal.pone.0182761 https://hdl.handle.net/2268/214327

BOEMER, F., JOSSE, C., LUIS, G., Di Valentin, E., Thiry, J., CELLO, C., CABERG, J.-H., DADOUMONT, C., HARVENGT, J., Lumaka, A., BOURS, V., & DEBRAY, F.-G. (18 February 2022). Novel Loss of Function Variant in BCKDK Causes a Treatable Developmental and Epileptic Encephalopathy. International Journal of Molecular Sciences, 23 (4), 2253. doi:10.3390/ijms23042253
Peer Reviewed verified by ORBi

Votion, D., François, A.-C., Renaud, B., Wouters, C., Farinelle, A., BOEMER, F., CELLO, C., Amory, H., Marcillaud-Pitel, C., Richard, E., & Gustin, P. (2019). La myopathie atypique : le top 10 des dernières nouvelles. In C. Mespoulhès, Proceeding Journée AVEF (Association des Vétérinaires Equins Français) (pp. 102-104). France: Association des Vétérinaires Equins Français.

François, A.-C., Renaud, B., Weber, M., Marcillaud-Pitel, C., BOEMER, F., Jourdan, M., CELLO, C., Richard, E., Gustin, P., & Votion, D. (May 2019). Comment confirmer le diagnostic de myopathie atypique ? [Poster presentation]. Journées Sciences et Innovations équines, Saumur, France.
Editorial reviewed

Votion, D., BOEMER, F., Marcillaud-Pitel, C., Jourdan, M., CELLO, C., François, A.-C., Renaud, B., Toquet, M. P., Cassart, D., Detilleux, J., & Richard, E. (March 2019). Point sur les outils diagnostiques et pronostiques de la myopathie atypique. Pratique Vétérinaire Équine, 201, 12-19.
Peer reviewed

BOEMER, F., Detilleux, J., CELLO, C., Amory, H., Marcillaud-Pitel, C., Richard, E., Van Galen, G., van Loon, G., Lefère, L., & Votion, D. (2017). Acylcarnitines profile best predicts survival in horses with atypical myopathy. PLoS ONE, 1-16. doi:10.1371/journal.pone.0182761
Peer Reviewed verified by ORBi

Marcillaud-Pitel, C., Baise, E., BOEMER, F., Habyarimana, J. B. A., Gustin, P., CELLO, C., Douny, C., Richard, E., Toquet, M.-P., Detilleux, J., Amory, H., Weber, M., Guez, A., & Votion, D. (2017). Point sur les travaux de recherche sur la myopathie atypique et leurs impacts sur la filière: quoi de neuf ? In Proceeding de la 43ème Journée de la Recherche équine (pp. 27-35).
Peer reviewed

BOEMER, F., Detilleux, J., Baise, E., CELLO, C., Amory, H., Marcillaud-Pitel, C., Richard, E., & Votion, D. (2016). Vivra, ne vivra pas ? Comment définir le pronostic de survie des cas de myopathie atypique ? In Journée AVEF (Association des Vétérinaires Equins Français) (pp. 150-151).
Peer reviewed

Contact ORBi